Effects of selective dopamine D2-receptor agonists on the release of cholecystokinin-like immunoreactivity from rat neostriatum
- 1 May 1984
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 101 (1-2) , 119-125
- https://doi.org/10.1016/0014-2999(84)90037-2
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Dopamine modulates cholecystokinin release in neostriatumNature, 1983
- Dopamine receptors explainedTrends in Neurosciences, 1982
- Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatumBrain Research, 1982
- Origin of the Cholecystokinin-Containing Fibers in the Rat CaudatoputamenScience, 1982
- Evidence that LY-141865 specifically stimulates the D-2 dopamine receptorNature, 1981
- Modulation of striatal [3H]-glutamic acid release by dopaminergic drugsLife Sciences, 1980
- Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levelsNeuropharmacology, 1980
- Multiple receptors for dopamineNature, 1979
- Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acidsNature, 1976
- Lesion of striatal neurons with kainic acid provides a model for Huntington's choreaNature, 1976